GenPrime Launches Medical Device in the U.S. Toxicology Market
August 24, 2016
SPOKANE, WA, August 26, 2016 – GenPrime, Inc., a Spokane based biotech company, launched its FDA cleared Point of Care (POC) diagnostic medical device, the POC Reader, in the $1.2B U.S. drug testing market with its partner company, Alere, Inc. based in Waltham, MA.
MEDICA Nov. 14 - 17
August 10, 2016
Come join us at MEDICA on November 14-17, 2016 in Dusseldorf, Germany. We will be at Hall 3 3/D29-7.